<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v3.0 20080202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing3.dtd?><?SourceDTD.Version 3.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Iran J Parasitol</journal-id><journal-id journal-id-type="iso-abbrev">Iran J Parasitol</journal-id><journal-id journal-id-type="publisher-id">IJPA</journal-id><journal-id journal-id-type="pmc">IJPA</journal-id><journal-title-group><journal-title>Iranian Journal of Parasitology</journal-title></journal-title-group><issn pub-type="ppub">1735-7020</issn><issn pub-type="epub">2008-238X</issn><publisher><publisher-name>Tehran University of Medical Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7548454</article-id><article-id pub-id-type="doi">10.18502/ijpa.v15i3.4201</article-id><article-id pub-id-type="publisher-id">IJPA-15-364</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Anthelmintic Efficacy of Supramolecular Complex of Praziquantel Obtained by Mechanochemical Technology</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>ARKHIPOV</surname><given-names>Ivan</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>KHALIKOV</surname><given-names>Salavat</given-names></name><xref ref-type="aff" rid="AFF2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>DUSHKIN</surname><given-names>Alexander</given-names></name><xref ref-type="aff" rid="AFF3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>SADOV</surname><given-names>Konstantin</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>METELEVA</surname><given-names>Elizaveta</given-names></name><xref ref-type="aff" rid="AFF3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>ARISOV</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>VARLAMOVA</surname><given-names>Anastasiya</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref><xref ref-type="corresp" rid="C1"><sup>*</sup></xref></contrib><aff id="AFF1"><label>1.</label> Department of Experimental Therapy, All-Russian Scientific Research Institute of Fundamental and Applied Parasitology of Animals and Plants, Branch of Federal Scientific Center of Experimental Veterinary Medicine, Russian Academy of Sciences, Moscow, Russia</aff><aff id="AFF2"><label>2.</label> Department of Physiologically Active Organofluorine Compounds, A.N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences, Moscow, Russia</aff><aff id="AFF3"><label>3.</label> Department of Mechanochemistry of Organic Compounds, Institute of Solid State Chemistry and Mechanochemistry of the Siberian Branch, Russian Academy of Sciences, Novosibirsk, Russia</aff></contrib-group><author-notes><corresp id="C1"><label>*</label><bold>Correspondence Email:</bold><email>arsphoeb@mail.ru</email></corresp></author-notes><pub-date pub-type="ppub"><season>Jul-Sep</season><year>2020</year></pub-date><volume>15</volume><issue>3</issue><fpage>364</fpage><lpage>373</lpage><history><date date-type="received"><day>19</day><month>10</month><year>2019</year></date><date date-type="accepted"><day>11</day><month>1</month><year>2020</year></date></history><permissions><copyright-statement>Copyright&#x000a9; Iranian Society of Parasitology &#x00026; Tehran University of Medical Sciences</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Background:</title><p>A supramolecular complex of praziquantel (PZQ) with disodium salt of glycyrrhizic acid (Na<sub>2</sub>GA) was obtained by mechanochemical technology to increase solubility, absorption rate and hence bioavailability of the drug and reduction its therapeutic doses. The aim of our study was evaluation of anthelmintic efficacy of supramolecular complex of PZQ.</p></sec><sec><title>Methods:</title><p>Different samples of PZQ with Na<sub>2</sub>GA were obtained by mechanochemical processing and examined for some physico-chemical properties. The anthelmintic activity of the most perspective samples was studied on the laboratory model of <italic>Hymenolepis nana</italic> infection of mice and <italic>Moniezia expansa</italic> infection of sheep by the results of helminthological necropsy of the small intestines (the controlled test).</p></sec><sec><title>Results:</title><p>A high efficacy (&#x0003e; 98%) of supramolecular complex of PZQ with Na<sub>2</sub>GA (1/10) was shown at doses of 3; 2 and 1 mg/kg of body weight at single oral administration against <italic>H. nana</italic> in mice and <italic>M. expansa</italic> in sheep. While the basic PZQ had 27.19% and 36.64% efficacy respectively at the dose of 1 mg/kg. The PZQ:Na<sub>2</sub>GA 1/10 physical mixture (without mechanochemical processing) revealed no anthelmintic efficacy.</p></sec><sec><title>Conclusion:</title><p>Joint mechanochemical treatment the PZQ substance and Na<sub>2</sub>GA led to increased solubility, reduction of particle sizes, amorphization of substance, incorporating it with micelles of glycyrrhizic acid and high anthelmintic efficacy in reduced dose. The supramolecular complex of praziquantel was found to be a perspective anthelminthic with enhanced pharmacological activity that needs further research.</p></sec></abstract><kwd-group><kwd>Efficacy</kwd><kwd>Praziquantel</kwd><kwd>Supramolecular complex</kwd><kwd>Mechanochemistry</kwd><kwd>Disodium salt of glycyrrhizic acid</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Praziquantel (PZQ) is the main drug for treatment of cestodosis of animals and humans (<xref rid="B1" ref-type="bibr">1</xref>&#x02013;<xref rid="B3" ref-type="bibr">3</xref>). However, high doses of PZQ (50&#x02013;100 mg/kg) are required to treat larval cestodosis of animals that restrict its practical application (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>). The high cost of the drug, as well as its high consumption for treatment of large animals (cattle, horses), restrain its use. In this regard, there was an interest in reducing the dose of the drug by increasing its solubility, absorbability and efficacy using mechanochemical technology to produce solid dispersions of anthelmintics with hydrophilic carriers - plant and synthetic polymers, as well as with lipophilic-hydrophobic substances as drug delivery systems.</p><p>As a carrier, we have used disodium salt of glycyrrhizic acid (Na<sub>2</sub>GA). An important feature of glycyrrhizic acid (GA) solutions is the possibility of including lipophilic low-soluble molecules in the structure of micelles or other self-associates, that significantly increase the overall concentration of their molecules in a free and bound form in aqueous solutions (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B7" ref-type="bibr">7</xref>). Nevertheless, the use of pure GA as a carrier of drug molecules has a disadvantage in the phenomenon of gelling of its concentrated solutions. The use of its disubstituted salts of alkali metal makes it possible to eliminate this phenomenon.</p><p>Thus, the aim of our study was to obtain a supramolecular complex of PZQ with Na<sub>2</sub>GA by mechanochemical technology and to study its physicochemical features and anthelmintic activity in comparison with the substance of original PZQ (without Na<sub>2</sub>GA) and with the physical mixture of PZQ:Na<sub>2</sub>GA 1/10 without mechanochemical processing.</p></sec><sec sec-type="materials|methods"><title>Materials and Methods</title><p>The research was blinded, randomized and placebo-controlled. Studies were carried out according to the adopted rules (<xref rid="B8" ref-type="bibr">8</xref>&#x02013;<xref rid="B10" ref-type="bibr">10</xref>). Council on Ethics at the Ministry of Health of Russia approved the trials. Clinical trials governmental registration protocol &#x02116; 615&#x02013;110; 25.09.2017.</p><p>Solid phase was conducted in one step of mechanochemical treatment of PZQ with Na<sub>2</sub>GA in a Ball Drum Mill LE-101 (Hungary) in a weight ratio of 1:5, 1:10 and 1:20 (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B12" ref-type="bibr">12</xref>).The drum was set on rolls and the mixture was processed for 4 h at a speed of 156 revolutions per minute; acceleration of grinding media - 1g with steel balls with diameter of 22 mm. Other samples were obtained by mechanochemical technology without an auxiliary substance - Na<sub>2</sub>GA by processing in planetary mill AGO-2 (Novosibirsk, Russia). Processing mode: acceleration of grinding media &#x02013; 20 g and 40 g, weight of the material &#x02013; 2.5 g, drum capacity &#x02013; 50 mL, grinding media-steel balls (diameter 6 mm, 75.0 g load), processing time &#x02013; 5 min (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B12" ref-type="bibr">12</xref>).</p><sec><title>Characterization</title><p>The solubility of samples was evaluated by dissolution (approx. 0.55 g) in distilled water (10 ml) in shaker-incubator at 37 &#x000b0;C and 200 rpm for three hours. The concentration of drug substances in solutions was analyzed by HPLC on Agilent 1200 (Agilent technologies, Santa Clara, USA) with a Zorbax Eclipse XDB-C18 column (50 &#x000d7; 4.6 mm) and diode-array detector; eluent: acetonitrile/acetate buffer pH 3.4 (1:2); detection on wavelength: 210 nm. The thermal analysis was conducted by Differential Scanning Calorimeter-550 (Instrument Scientific Specialists Inc., Twin Lakes, USA) in argon atmosphere (20&#x02013;250 &#x000b0;C; rate of heating: 10 &#x000b0;C/min). The morphology of tested substances was studied by Hitachi microscope TM-1000 (Hitachi High-Technologies Corp., Tokyo, Japan). Diffractometer DRON-4 was used for X-ray analysis with CuK<sub>&#x003b1;</sub>-radiation at 2 deg/min (l=1000) in the angle range of 4&#x02013;65 degrees (Bourevestnik Inc., St. Petersburg, Russia). The method of Higuchi and Connors was used for phase solubility studies (<xref rid="B13" ref-type="bibr">13</xref>). After equilibrium of dissolved samples was reached, the suspensions were centrifuged (12000 rpm; 10 min). Super-natants were filtered and examined for PZQ concentration by HPLC. The total molar concentration of Na<sub>2</sub>GA (&#x00425;-axis) and the total molar concentration of PZQ (Y-axis) were used for construction of the phase solubility diagram. In vitro parallel artificial membrane permeability assay (PAMPA) experiment was conducted in 12-well filter plates (polycarbonate membrane, 12 mm diameter, 0.4 &#x003bc;m pore size, 1.12 cm<sup>2</sup> area, Corning Incorporated) to predict passive intestinal absorption (<xref rid="B14" ref-type="bibr">14</xref>). The artificial membrane was saturated by pipetting 60 &#x003bc;L of the 5% hexadecane in hexane solution to each wells of the donor plate. After hexane evaporation about 1.5 mL of distilled water was added to each wells of the acceptor plate. The hexadecane treated donor plate was then placed on top of the 12-well acceptor plate. Then, 0.5 mL of PZQ or its compositions solutions in distilled water were added to each well of the donor plate, and the plate was placed in shaker-incubator for 2.5 h (37 &#x000b0;C, 200 rpm). Samples (1 mL) were collected from the acceptor plate at appropriate time points (0.25h, 0.5 h, 0.75h, 1.0 h, 1.25h, 1.5 h, 1.75h, 2 h, 2.25h, 2.5h) and were analyzed by HPLC, and the same volume of distilled water was replenished. All these methods have been described previously (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B15" ref-type="bibr">15</xref>&#x02013;<xref rid="B17" ref-type="bibr">17</xref>).</p></sec><sec sec-type="methods"><title>Study Animals</title><sec><title>H. nana infection of mice</title><p>The study of the efficacy of supramolecular complex of PZQ with Na<sub>2</sub>GA (1:10) against <italic>H. nana</italic> infection of mice was conducted on 50 inbred white mice BALB/c (Branch Stolbovaya FSBES of NCBMT FMBA of Russia) of both sexes (16&#x02013;18 g). Mice were quarantined and adapted for 7 days before the experiment. Then animals were divided into polycarbonate cages of 6 animals each in the vivarium with controlled environment of 20&#x02013;22 &#x000b0;C and humidity of 60&#x02013;70 %. Mice received rat feed (LLC Laboratorkorm, Moscow, Russia) according to the daily feed rate of the Russian Federation (<xref rid="B18" ref-type="bibr">18</xref>). Water was provided <italic>ad libitum</italic> during the study. Animals were randomly selected in groups by the method of random numbers and with the same body weight for the trials.</p><p>Cestodes of <italic>H. nana</italic> collected from the previous infection were destroyed in a small volume of tap water by repeatedly sucking into a syringe with a needle-cannula. About 200 infective eggs of <italic>H. nana</italic> were administered orally to each mouse with a disposable syringe of 1 ml connected to 25 mm needle. After infection - on the 5<sup>th</sup> day after inoculation, the feces were examined daily by the sedimentation method in order to find eggs of <italic>H. nana</italic> (<xref rid="B19" ref-type="bibr">19</xref>).</p></sec><sec><title>Monieziosis of sheep</title><p>The anthelmintic activity of supramolecular complex of PZQ was studied in sheep farm of Samara region (LTD Agro resource), where high levels of <italic>Moniezia expansa</italic> and <italic>Moniezia benedeni</italic> infection have been registered. Experiments were conducted during the period of maximum infection on 60 young sheep of Stavropol Merino breed weighing from 17 to 32 kg in 2017. Sheep were kept indoors and fed according to the norms and rations of feeding livestock (<xref rid="B20" ref-type="bibr">20</xref>). Water was provided <italic>ad libitum</italic> during the experiment. Fecal examinations were made by the standard fecal examination techniques before the study for random distribution of sheep into the experimental groups with the same number of eggs per gram of feces (<xref rid="B21" ref-type="bibr">21</xref>).</p></sec><sec sec-type="materials"><title>Materials</title><p>PZQ (2-(Cyclohexylcarbonyl)-1,2,3,6,7-11bhexahydro-4<italic>H</italic>-pyrazino[2,1-<italic>a</italic>]isoquinolin-4-one), 98.5%, average Mw ~ 312.41 was purchased from Rensin Chemicals Limited (Nanjing, China). Na2GA was purchased from Shaanxi Sciphar Biotechnology Co. LTD (Xian, China). All other chemicals and solvents were of analytical reagent grade.</p></sec><sec><title>Experimental groups</title><p>One control group and 5 experimental groups of 10 animals were formed randomly on the 13<sup>th</sup> day after infection by the results of feces examination by McMaster method (<xref rid="B21" ref-type="bibr">21</xref>). The supramolecular complex of PZQ with Na<sub>2</sub>GA was administered intragastrically to the mice of the 1&#x02013;3 experimental groups with a stainless steel bulb tipped gavage needle in a dosage rate of 3.0; 2.0 and 1.0 mg/kg of active substance. The 4<sup>th</sup> experimental group received basic PZQ at the dose of 1.0 mg/kg of b/w. One percent starch gel was given to the animals of control group. PZQ: Na<sub>2</sub>GA1/10 physical mixture was administered to the animals of the fifth group at the dose 2 mg/kg of active substance. The animals were sacrificed by cervical dislocation on the 4<sup>th</sup> day after drugs administration.</p><p>Sheep naturally infected with monieziosis were divided into 5 equal groups of 10&#x02013;12 animals each by the results of feces examination by McMaster technique (<xref rid="B21" ref-type="bibr">21</xref>). The supramolecular complex of PZQ with Na<sub>2</sub>GA was administered orally to the animals of the first, second and third groups in the form of 10 % powder once at doses of 1.0, 2.0 and 3.0 mg/kg of b/w respectively. Sheep of the 4<sup>th</sup> received a basic drug &#x02013; PZQ at the dose of 1.0 mg/kg. The animals of the control group received no preparation.</p></sec><sec sec-type="methods"><title>Procedures</title><p>The efficacy of the supramolecular complex of PZQ with Na<sub>2</sub>GA against <italic>H. nana</italic> infection of mice was evaluated on the 4<sup>th</sup> day after drug administration by the results of helminthological necropsy of mice intestines. Recovered cestodes were counted. The anthelmintic activity was determined by the results of controlled test (<xref rid="B22" ref-type="bibr">22</xref>). Identification of <italic>M. expansa</italic> was based on the distinct morphology of helminthes by the results of helminthological necropsy of sheep intestines on the 10<sup>th</sup> day after treatment (<xref rid="B23" ref-type="bibr">23</xref>).</p></sec></sec><sec sec-type="methods"><title>Statistical methods</title><p>Statistical analysis of data was performed on geometric mean of number of parasites using the parametric <italic>t</italic>-test to compare differences between treatment groups and control groups for significance at the <italic>P</italic> &#x02264; 0.05. Statistical analysis of data was evaluated by SAS/Stat (version &#x02116;9.4 of the SAS System for Windows) software.</p></sec></sec><sec sec-type="results"><title>Results</title><p>The micrographs obtained by electronic scanning microscopy showed that the initial PZQ consists of crystalline elongated particles of 10&#x02013;20 &#x003bc;m in size and their aggregates up to 500 &#x003bc;m (<xref ref-type="fig" rid="F1">Fig. 1</xref> A). The sample of PZQ after processing in a planetary mill for 5 min at 20 g consists of particles mainly with a size of 50&#x02013; 100 &#x003bc;m (<xref ref-type="fig" rid="F1">Fig. 1B</xref>) and the sample after processing for 5 min at 40 g have the aggregates with sizes of 150&#x02013;200 &#x003bc;m (<xref ref-type="fig" rid="F1">Fig. 1C</xref>). Probably, an increase in the size of the aggregates in the latter case is associated with partial melting of the substance and subsequent sticking. The initial Na<sub>2</sub>GA consists of spherical particles with a size of 5&#x02013;50 &#x003bc;m (<xref ref-type="fig" rid="F1">Fig. 1D</xref>). The particles of the initial substances were crushed to poly-disperse powder consisting of particles with an average size of 5&#x02013;20 &#x003bc;m and their aggregates after joint mechanochemical processing of PZQ and Na<sub>2</sub>GA (<xref ref-type="fig" rid="F1">Fig. 1E</xref>). It can be assumed that PZQ is not a highly crystalline substance based on broadening of the reflexes on the radiographs of original PZQ (<xref ref-type="fig" rid="F2">Fig. 2</xref>).</p><fig id="F1" orientation="portrait" position="float"><label>Fig. 1:</label><caption><p>Electron micrographs of initial substance of praziquntel (A); B. praziquantel processed in AGO-2 mill (20g, 5 min.); C. praziquantel processed in AGO-2 mill (40g, 5 min.); D. Na<sub>2</sub>GA; E. praziquantel/Na<sub>2</sub>GA 1/10 processed in ball drum mill for 4 hours obtained by mechanochemical technology (1/10)</p></caption><graphic xlink:href="IJPA-15-364-g001"/></fig><fig id="F2" orientation="portrait" position="float"><label>Fig. 2:</label><caption><p>Radiographs of XRA of: 1. praziquantel; 2. praziquantel processed in AGO-2 mill (20g, 5 min.); 3. praziquantel processed in AGO-2 mill (40g, 5 min.); 4. Na<sub>2</sub>GA; 5. physical mixture of praziquantel/Na<sub>2</sub>GA 1/10; 6. praziquantel/Na<sub>2</sub>GA 1/10 processed in ball drum mill for 4 hours</p></caption><graphic xlink:href="IJPA-15-364-g002"/></fig><p>Moreover, its enthalpy of melting is ~ 90 J/g. The type of radiograph does not change significantly, the enthalpy of melting slightly decreases to 85 J/g after processing of PZQ in a planetary mill at 20 g for 5 minutes. The intensity of the reflexes on radiographs decreases after processing of PZQ in a planetary mill at 40 g for 5 min, but complete amorphization does not occur; the enthalpy of melting is 80 J/g. X-ray analysis and thermal analysis of supramolecular complex of PZQ with Na<sub>2</sub>GA indicated a loss of crystallinity of the initial components up to the formation of amorphous phases.</p><p>At the same time PZQ is distributed in the excess of the amorphous matrix of Na<sub>2</sub>GA, thereby greatly facilitating the formation of the guest-host system (<xref ref-type="fig" rid="F2">Fig. 2</xref>&#x02013;<xref ref-type="fig" rid="F3">3</xref>).</p><fig id="F3" orientation="portrait" position="float"><label>Fig. 3:</label><caption><p>Differential scanning calorimetric thermal curves of: 1. praziquantel; 2. praziquantel processed in AGO-2 mill (20g, 5 min.); 3. praziquantel processed in AGO-2 mill (40g, 5 min.); 4. Na<sub>2</sub>GA; 5. physical mixture of praziquantel/Na<sub>2</sub>GA 1/10; 6. praziquantel/Na<sub>2</sub>GA 1/10 processed in ball drum mill for 4 hours</p></caption><graphic xlink:href="IJPA-15-364-g003"/></fig><p>In all cases, an increase in the solubility of PZQ after mechanochemical processing can be observed, which indicates the formation of intermolecular complexes of PZQ and Na<sub>2</sub>GA. The <xref rid="T1" ref-type="table">table 1</xref> shows the maximum achieved solubility values. The HPLC data also confirmed that no degradation or chemical interactions involving molecules of PZQ have occurred.</p><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1:</label><caption><p>The solubility of PZQ and its compositions</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1"><bold><italic>The composition of the sample, the weight ratio, the production method</italic></bold></th><th align="center" valign="top" rowspan="1" colspan="1"><bold><italic>Concentration of PZQ in water, g/l</italic></bold></th><th align="center" valign="top" rowspan="1" colspan="1"><bold><italic>The increase in solubility, n</italic></bold></th><th align="center" valign="top" rowspan="1" colspan="1"><bold><italic>The content of PZQ, % of theoretically</italic></bold></th><th align="center" valign="top" rowspan="1" colspan="1"><bold><italic>pH</italic></bold></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Initial PZQ</td><td align="center" valign="top" rowspan="1" colspan="1">0.234</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">7.2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PZQ/Na<sub>2</sub>GA 1/10 physical mixture</td><td align="center" valign="top" rowspan="1" colspan="1">0,566</td><td align="center" valign="top" rowspan="1" colspan="1">1.42</td><td align="center" valign="top" rowspan="1" colspan="1">100</td><td align="center" valign="top" rowspan="1" colspan="1">5.9</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PZQ/Na<sub>2</sub>GA 1/5 &#x0043c;/ch</td><td align="center" valign="top" rowspan="1" colspan="1">0.557</td><td align="center" valign="top" rowspan="1" colspan="1">1.94</td><td align="center" valign="top" rowspan="1" colspan="1">99.9</td><td align="center" valign="top" rowspan="1" colspan="1">5.8</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PZQ/Na<sub>2</sub>GA1/10 &#x0043c;/ch</td><td align="center" valign="top" rowspan="1" colspan="1">0.687</td><td align="center" valign="top" rowspan="1" colspan="1">2.94</td><td align="center" valign="top" rowspan="1" colspan="1">99.6</td><td align="center" valign="top" rowspan="1" colspan="1">6.0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PZQ/Na<sub>2</sub>GA1/20 &#x0043c;/ch</td><td align="center" valign="top" rowspan="1" colspan="1">0.817</td><td align="center" valign="top" rowspan="1" colspan="1">3.49</td><td align="center" valign="top" rowspan="1" colspan="1">100.0</td><td align="center" valign="top" rowspan="1" colspan="1">6.2</td></tr></tbody></table></table-wrap><p>The phase diagrams of the solubility of PZQ from the compositions at different temperatures (<xref ref-type="fig" rid="F4">Fig. 4</xref>, <xref rid="T2" ref-type="table">Table 2</xref>) were evaluated to prove intermolecular interactions in the aqueous solutions of PZQ with Na<sub>2</sub>GA and to estimate the stoichiometric and thermodynamic parameters of the inclusion of PZQ molecules into GA micelles. The resulting diagrams correspond to &#x00410;<sub>L</sub>-type, which implies the formation of a complex with the stoichiometric ratio PZQ/Na<sub>2</sub>GA micelle 1/1.</p><fig id="F4" orientation="portrait" position="float"><label>Fig. 4:</label><caption><p>Phase diagrams of the solubility of PZQ/Na<sub>2</sub>GA 1/10 (mass) compositions in aqueous solutions at different temperatures</p></caption><graphic xlink:href="IJPA-15-364-g004"/></fig><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2:</label><caption><p>Thermodynamic parameters of the inclusion of PZQ molecules into micelles in Na<sub>2</sub>GA solution (mean&#x000b1;SE, n=3)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1"><bold><italic>T, &#x000b0;C</italic></bold></th><th align="center" valign="top" rowspan="1" colspan="1"><bold><italic>K, M<sup>&#x02212;1</sup></italic></bold></th><th align="center" valign="top" rowspan="1" colspan="1"><bold><italic>&#x00394;G, kJ/mol</italic></bold></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">+30</td><td align="center" valign="top" rowspan="1" colspan="1">23.7&#x000b1;0.6</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;8.0&#x000b1;0.1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">+37</td><td align="center" valign="top" rowspan="1" colspan="1">18.6&#x000b1;0.4</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;7.5&#x000b1;0.1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">+42</td><td align="center" valign="top" rowspan="1" colspan="1">17.8&#x000b1;0.3</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;7.6&#x000b1;0.1</td></tr></tbody></table></table-wrap><p>The results of the measurement of trans-membrane transfer are shown in <xref ref-type="fig" rid="F5">Fig. 5</xref>. Evidently the rate of diffusion of PZQ molecules from its composition with Na<sub>2</sub>GA is much higher than that for initial PZQ substance. A substantial nearly 2-fold (for experiment duration 1 h) acceleration of transmembrane transfer from the solution of the complex was observed.</p><fig id="F5" orientation="portrait" position="float"><label>Fig. 5:</label><caption><p>Membrane permeability of praziquantel. 1 &#x02013; initial PZQ, 2 - PZQ/Na<sub>2</sub>GA 1/10</p></caption><graphic xlink:href="IJPA-15-364-g005"/></fig><p>The sample selected on the basis of the best physicochemical properties &#x02013; the supramolecular complex of PZQ with Na<sub>2</sub>GA (1:10) was tested on the anthelmintic efficacy on the laboratory model of <italic>H. nana</italic> infection of mice and <italic>M. expansa</italic> infection of sheep.</p><p>This study demonstrated 100 % efficacy of supramolecular complex of PZQ at the dose of 3 mg/kg (<xref rid="T3" ref-type="table">Table 3</xref>) in <italic>H. nana</italic> infection of mice while the unmodified PZQ showed 27.19 % efficacy. At necropsy, 10 adults of <italic>H. nana</italic> were found in the small intestine of mice of control group indicating the presence of an established infection. Statistically all the treatment groups had significantly fewer number of <italic>H. nana</italic> (<italic>P</italic> &#x0003c; 0.001) compared with the control group. Thus, on average, 0.032 and 0.264 <italic>H. nana</italic> (geometric mean) were detected in the small intestines of mice after administration of supramolecular complex of PZQ at doses of 2.0 and 1.0 mg/kg respectively. The PZQ:Na<sub>2</sub>GA1/10 physical mixture revealed no anthelmintic efficacy.</p><table-wrap id="T3" orientation="portrait" position="float"><label>Table 3:</label><caption><p><italic>Hymenolepis nana</italic> geometric counts, efficacy and statistical significance for treatment group (n = 10)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1"><bold><italic>Group of animals</italic></bold></th><th align="center" valign="top" rowspan="1" colspan="1"><bold><italic>Supramolecular complex and its composition</italic></bold></th><th align="center" valign="top" rowspan="1" colspan="1"><bold><italic>Dose, mg of active substance/kg of body weight</italic></bold></th><th align="center" valign="top" rowspan="1" colspan="1"><bold><italic>Geometric mean of worms</italic></bold></th><th align="center" valign="top" rowspan="1" colspan="1"><bold><italic>Efficacy<xref ref-type="table-fn" rid="TFN1"><sup>a</sup></xref> (%)</italic></bold></th><th align="center" valign="middle" rowspan="1" colspan="1"><bold><italic>P-Value</italic></bold></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Control</td><td align="center" valign="top" rowspan="1" colspan="1">Placebo</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;</td><td align="center" valign="top" rowspan="1" colspan="1">24.423</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Treatment</td><td align="center" valign="top" rowspan="1" colspan="1">PZQ:Na<sub>2</sub>GA</td><td align="center" valign="top" rowspan="1" colspan="1">3.0</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">100</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c; 0.0001<xref ref-type="table-fn" rid="TFN2"><sup>*</sup></xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Treatment</td><td align="center" valign="top" rowspan="1" colspan="1">PZQ:Na<sub>2</sub>GA</td><td align="center" valign="top" rowspan="1" colspan="1">2.0</td><td align="center" valign="top" rowspan="1" colspan="1">0.032</td><td align="center" valign="top" rowspan="1" colspan="1">99.99</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c; 0.0001<xref ref-type="table-fn" rid="TFN2"><sup>*</sup></xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Treatment</td><td align="center" valign="top" rowspan="1" colspan="1">PZQ:Na<sub>2</sub>GA</td><td align="center" valign="top" rowspan="1" colspan="1">1.0</td><td align="center" valign="top" rowspan="1" colspan="1">0.264</td><td align="center" valign="top" rowspan="1" colspan="1">98.92</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c; 0.001<xref ref-type="table-fn" rid="TFN2"><sup>*</sup></xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Treatment</td><td align="center" valign="top" rowspan="1" colspan="1">PZQ substance</td><td align="center" valign="top" rowspan="1" colspan="1">1.0</td><td align="center" valign="top" rowspan="1" colspan="1">17.783</td><td align="center" valign="top" rowspan="1" colspan="1">27.19</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;0.05<xref ref-type="table-fn" rid="TFN2"><sup>*</sup></xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Treatment</td><td align="center" valign="top" rowspan="1" colspan="1">PZQ:Na<sub>2</sub>GA1/10 physical mixture</td><td align="center" valign="top" rowspan="1" colspan="1">2.0</td><td align="center" valign="top" rowspan="1" colspan="1">16.5</td><td align="center" valign="top" rowspan="1" colspan="1">32.44</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;0.05<xref ref-type="table-fn" rid="TFN2"><sup>*</sup></xref></td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><label>a</label><p>Percent efficacy based on geometric means</p></fn><fn id="TFN2"><label>*</label><p>Statistically significant at <italic>P</italic> &#x02264; 0.05 when geometric means were compared to placebo</p></fn></table-wrap-foot></table-wrap><p>The study showed 100 % efficacy of supra-molecular complex of PZQ against <italic>M. expansa</italic> infection of sheep at the dose of 3.0 mg/kg of b/w (<xref rid="T4" ref-type="table">Table 4</xref>). Worms of <italic>M. expansa</italic> were found in the small intestine of sheep after administration of supramolecular complex of PZQ at doses of 2.0 and 1.0 mg/kg of b/w in the amount of 0.003 and 0.064 parasites per animal. The efficacy was 99.91 and 98.18 % respectively based on the geometric mean counts. At necropsy sheep of all the treatment groups had significantly fewer <italic>M. expansa</italic> worms (<italic>P</italic>&#x0003c;0.0001) compared with the control group. The unmodified PZQ showed 36.64 % efficacy against <italic>M. expansa</italic> infection at the dose of 1 mg/kg.</p><table-wrap id="T4" orientation="portrait" position="float"><label>Table 4:</label><caption><p><italic>Moniesia expansa</italic> geometric counts, efficacy and statistical significance for treatment group</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1"><bold><italic>Group of animals</italic></bold></th><th align="center" valign="top" rowspan="1" colspan="1"><bold><italic>Supramolecular complex and its composition</italic></bold></th><th align="center" valign="top" rowspan="1" colspan="1"><bold><italic>Dose, mg of active substance/kg of body weight</italic></bold></th><th align="center" valign="top" rowspan="1" colspan="1"><bold><italic>Number of sheep in group</italic></bold></th><th align="center" valign="top" rowspan="1" colspan="1"><bold><italic>Geometric mean of worms</italic></bold></th><th align="center" valign="top" rowspan="1" colspan="1"><bold><italic>Efficacy<xref ref-type="table-fn" rid="TFN3"><sup>a</sup></xref> (%)</italic></bold></th><th align="center" valign="top" rowspan="1" colspan="1"><bold><italic>P-Value</italic></bold></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Control</td><td align="center" valign="top" rowspan="1" colspan="1">Placebo</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;</td><td align="center" valign="top" rowspan="1" colspan="1">10</td><td align="center" valign="top" rowspan="1" colspan="1">3.524</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td><td align="center" valign="top" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Treatment</td><td align="center" valign="top" rowspan="1" colspan="1">PZQ:Na<sub>2</sub>GA</td><td align="center" valign="top" rowspan="1" colspan="1">3.0</td><td align="center" valign="top" rowspan="1" colspan="1">10</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">100</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c; 0.0001<xref ref-type="table-fn" rid="TFN4"><sup>*</sup></xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Treatment</td><td align="center" valign="top" rowspan="1" colspan="1">PZQ:Na<sub>2</sub>GA</td><td align="center" valign="top" rowspan="1" colspan="1">2.0</td><td align="center" valign="top" rowspan="1" colspan="1">11</td><td align="center" valign="top" rowspan="1" colspan="1">0.003</td><td align="center" valign="top" rowspan="1" colspan="1">99.91</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c; 0.001<xref ref-type="table-fn" rid="TFN4"><sup>*</sup></xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Treatment</td><td align="center" valign="top" rowspan="1" colspan="1">PZQ:Na<sub>2</sub>GA</td><td align="center" valign="top" rowspan="1" colspan="1">1.0</td><td align="center" valign="top" rowspan="1" colspan="1">12</td><td align="center" valign="top" rowspan="1" colspan="1">0.064</td><td align="center" valign="top" rowspan="1" colspan="1">98.18</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c; 0.001<xref ref-type="table-fn" rid="TFN4"><sup>*</sup></xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Treatment</td><td align="center" valign="top" rowspan="1" colspan="1">PZQ substance</td><td align="center" valign="top" rowspan="1" colspan="1">1.0</td><td align="center" valign="top" rowspan="1" colspan="1">11</td><td align="center" valign="top" rowspan="1" colspan="1">2.233</td><td align="center" valign="top" rowspan="1" colspan="1">36.64</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;0.05<xref ref-type="table-fn" rid="TFN4"><sup>*</sup></xref></td></tr></tbody></table><table-wrap-foot><fn id="TFN3"><label>a</label><p>Percent efficacy based on geometric means</p></fn><fn id="TFN4"><label>*</label><p>Statistically significant at <italic>P</italic> &#x02264; 0.05 when geometric means were compared to placebo</p></fn></table-wrap-foot></table-wrap><p>On average, 3.52 <italic>M. expansa</italic> worms were found in the small intestine of sheep in the control group that demonstrated an established infection of sheep in current study.</p></sec><sec sec-type="discussion"><title>Discussion</title><p>PZQ is the main drug for the treatment of humans and animals&#x02019; opisthorchiasis, clonorchosis, schistosomiasis, echinococcosis, cysticercosis, hymenolepiasis and other intestinal cestodosis (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B24" ref-type="bibr">24</xref>). Insufficient efficacy of PZQ in some helminthosis, including schistosomiasis, opisthorchiasis is caused by its low solubility and rapid metabolism in the liver with forming inactive compounds (<xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B26" ref-type="bibr">26</xref>). In this regard, the drug is used in an increased dose and in several ways to achieve maximum efficacy. Polyvinylpyrrolidone (<xref rid="B27" ref-type="bibr">27</xref>), polysaccharides (<xref rid="B11" ref-type="bibr">11</xref>,<xref rid="B15" ref-type="bibr">15</xref>), GA, Na<sub>2</sub>GA (<xref rid="B6" ref-type="bibr">6</xref>), are also used as a means for targeted delivery of anthelmintics. GA is able to form self-associates - micelles in aqueous solution because of the amphiphilic structure (<xref rid="B7" ref-type="bibr">7</xref>). In this case, poorly soluble molecules of medicinal substances are included in the structures of micelles and thereby increase their concentration in solution. The best solution in this respect is Na<sub>2</sub>GA as a &#x0201c;vehicle&#x0201d; (<xref rid="B28" ref-type="bibr">28</xref>).</p><p>Our studies of physicochemical properties confirmed an increase in the solubility of the supramolecular complex of PZQ with Na<sub>2</sub>GA in comparison with basic PZQ and the loss of its crystallinity up to the formation of amorphous phases. Solubility changed depending on the mass ratio of the components, the method of obtaining the compositions and time of mechanochemical processing. Since an increase in the proportion of PZQ leads to decrease in solubility and an increase in the proportion of Na<sub>2</sub>GA overloads the dosage form for oral administration. Therefore, 1/10 mass ratio of PZQ/Na<sub>2</sub>GA was optimal for further studies and had a good solubility index. Thermal and X-ray analyses showed that reflexes and melting peaks that are characteristic of the initial crystalline phase of PZQ have disappeared after mechanochemical processing. It can be assumed that molecules of PZQ are distributed in the amorphous Na<sub>2</sub>GA matrix, thereby greatly facilitating the formation of the guest-host system, where the guest is the molecules of PZQ and the host is the Na<sub>2</sub>GA carrier. This distribution significantly changes the properties of the drug and facilitates its release and transfer through biological membranes (<xref rid="B29" ref-type="bibr">29</xref>). The micrographs obtained by electronic scanning microscopy revealed that reduction of the size of particles of supramolecular complex of PZQ. The occurrence of the intermolecular interaction of PZQ with the micelles of GA in solution was demonstrated by means of phase solubility. Investigation of the permeability of PZQ through the artificial membrane by PAMPA assay demonstrated that the rate of PZQ molecule diffusion from its composition with Na<sub>2</sub>GA is much higher than that of initial PZQ.</p><p>In the present study the efficacy of the supramolecular complex of PZQ with Na<sub>2</sub>GA was three times higher than the efficacy of the substance of PZQ in the experiment carried out on white mice experimentally infected with <italic>H. nana</italic> and sheep naturally infected with moniezia at the dose of 1 mg/kg of b/w.</p></sec><sec sec-type="conclusion"><title>Conclusion</title><p>Joint mechanochemical processing of the PZQ substance and Na<sub>2</sub>GA led to reduction of particle sizes, increased solubility, amorphization of substance, incorporating it with micelles of GA and high anthelmintic efficacy in reduced dose. The supramolecular complex of praziquantel was found to be a perspective anthelminthic with enhanced pharmacological activity that needs further research.</p></sec><sec><title>Ethical considerations</title><p>Ethical issues (Including plagiarism, informed consent, misconduct, data fabrication and/or falsification, double publication and/or submission, redundancy, etc.) have been completely observed by the authors.</p></sec></body><back><ack><title>Acknowledgements</title><p>This research was carried out within the State Assignment to ISSCM SB RAS (project 0301-2019-0008) and was supported by the Ministry of Science and Higher Education of the Russian Federation. The authors would like to thank the technical support of specialists of LTD Agro resource of Samarskaya region.</p></ack><fn-group><fn fn-type="COI-statement"><p><bold>Conflict of interest</bold></p><p>The authors declare that there is no conflict of interest.</p></fn></fn-group><ref-list><title>References</title><ref id="B1"><label>1.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sergiev</surname><given-names>VP.</given-names></name></person-group>
<source>Atlas of clinical parasitology and tropical medicine</source>. <publisher-loc>Moscow</publisher-loc>: <publisher-name>Author&#x02019;s Academy</publisher-name>; <year>2010</year>.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>WC</given-names></name><name><surname>Rew</surname><given-names>RS.</given-names></name></person-group>
<source>Chemotherapy of parasitic diseases</source>. <publisher-loc>New York and London</publisher-loc>: <publisher-name>Plenum Press</publisher-name>; <year>1986</year>.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>H</given-names></name><name><surname>G&#x000f6;nnert</surname><given-names>R</given-names></name><name><surname>Pohlke</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>A new compound against adult tapeworms</article-title>. <conf-name>Thessoloniki: Proc of the 7th Int Conf of the World Ass for the Advancement of Vet Parasitol</conf-name>; <year>1975</year>.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrews</surname><given-names>P</given-names></name><name><surname>Thomas</surname><given-names>H</given-names></name><name><surname>Pohlke</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Praziquantel</article-title>. <source>Med Res Rev</source>. <year>1983</year>; <volume>3</volume>(<issue>2</issue>):<fpage>147</fpage>&#x02013;<lpage>200</lpage>.<pub-id pub-id-type="pmid">6408323</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Riviere</surname><given-names>JE</given-names></name><name><surname>Papich</surname><given-names>MG.</given-names></name></person-group>
<source>Veterinary pharmacology &#x00026; Therapeutics</source>. <edition>9th ed</edition>
<publisher-loc>Hoboken</publisher-loc>: <publisher-name>Willey Blackwell</publisher-name>; <year>2009</year>.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Graebin</surname><given-names>CS</given-names></name><name><surname>Merillon</surname><given-names>JM</given-names></name><name><surname>Ramawat</surname><given-names>K.</given-names></name></person-group>
<article-title>The pharmacological activities of glycyrrhizinic acid (&#x0201c;glycyrrhizin&#x0201d;) and glycyrrhetinic acid</article-title>. In: editors. Sweeteners. <source>Nature Public Health Emergency Collectio</source>. <year>2017</year> p. <fpage>245</fpage>&#x02013;<lpage>261</lpage>.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Dushkin</surname><given-names>AV</given-names></name><name><surname>Tolstikova</surname><given-names>TG</given-names></name><name><surname>Khvostov</surname><given-names>MV</given-names></name><etal/></person-group>
<article-title>Complexes of polysaccharides and glycyrrhizic acid with drug molecules. Mechano-chemical synthesis and pharmacological activity</article-title>. In: <person-group person-group-type="editor"><name><surname>Karunaratn</surname><given-names>DN</given-names></name></person-group>, editor. <source>The complex world of polysaccharides</source>. <publisher-loc>Rijeka</publisher-loc>: <publisher-name>InTech</publisher-name>; <year>2012</year> p. <fpage>573</fpage>&#x02013;<lpage>602</lpage>.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Habriev</surname><given-names>RU.</given-names></name></person-group>
<source>The guidance to experimental (preclinical) studying of new pharmacological substances</source>. <publisher-loc>Moscow</publisher-loc>: <publisher-name>Publishing House Medicine</publisher-name>; <year>2005</year>.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="other"><article-title>The order of the Ministry of Health of the Russian Federation, April 1st, 2016, No. 200</article-title>. On the approval of the rules of good clinical practice.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="other"><article-title>European Convention for the Protection of Vertebrate Animals used for experimental and other scientific purposes</article-title>. Strasbourg, <year>1986</year>.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meteleva</surname><given-names>ES</given-names></name><name><surname>Chistyachenko</surname><given-names>YS</given-names></name><name><surname>Suntsova</surname><given-names>LP</given-names></name><etal/></person-group>
<article-title>Physicochemical properties and anti-opisthorchosis effect of mechanochemically synthesized solid compositions of praziquantel with glycyrrhizic acid disodium salt</article-title>. <source>Dokl Biochem Biophys</source>. <year>2018</year>; <volume>481</volume>:<fpage>228</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="pmid">30168067</pub-id></mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Polyakov</surname><given-names>NE</given-names></name><name><surname>Chistyachenko</surname><given-names>YS</given-names></name><etal/></person-group>
<article-title>Preparation of curcumin self-micelle solid dispersion with enhanced bioavailability and cytotoxic activity by mechanochemistry</article-title>. <source>Drug Deliv</source>. <year>2018</year>; <volume>25</volume>(<issue>1</issue>):<fpage>198</fpage>&#x02013;<lpage>209</lpage>.<pub-id pub-id-type="pmid">29302995</pub-id></mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Higuchi</surname><given-names>TA</given-names></name><name><surname>Connors</surname><given-names>KA.</given-names></name></person-group>
<article-title>Phase solubility techniques</article-title>. In: <person-group person-group-type="editor"><name><surname>Reilley</surname><given-names>CN</given-names></name></person-group>, editor. <source>Advances in Analytical Chemistry and Instrumentation</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Wiley-Interscience</publisher-name>; <year>1965</year> p. <fpage>117</fpage>&#x02013;<lpage>212</lpage>.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kansy</surname><given-names>M</given-names></name><name><surname>Senner</surname><given-names>F</given-names></name><name><surname>Gubernator</surname><given-names>K.</given-names></name></person-group>
<article-title>Physico-chemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes</article-title>. <source>J Med Chem</source>. <year>1998</year>; <volume>41</volume>(<issue>7</issue>):<fpage>1007</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="pmid">9544199</pub-id></mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khalikov</surname><given-names>SS</given-names></name><name><surname>Chistyachenko</surname><given-names>YS</given-names></name><name><surname>Dushkin</surname><given-names>AV</given-names></name><etal/></person-group>
<article-title>Development of anthelmintic drugs of increased efficiency on the basis of intermolecular complexes of active substances with water-soluble polymers including polysaccharides</article-title>. <source>J Chem Sustain Dev</source>. <year>2015</year>; <volume>5</volume>:<fpage>567</fpage>&#x02013;<lpage>77</lpage>.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arkhipov</surname><given-names>IA</given-names></name><name><surname>Sadov</surname><given-names>KM</given-names></name><name><surname>Limova</surname><given-names>YV</given-names></name><etal/></person-group>
<article-title>The efficacy of the supramolecular complexes of niclosamide obtained by mechanochemical technology and targeted delivery against cestode infection of animals</article-title>. <source>Vet Parasitol</source>. <year>2017</year>; <volume>246</volume>:<fpage>25</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">28969776</pub-id></mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arkhipov</surname><given-names>IA</given-names></name><name><surname>Engasheva</surname><given-names>ES</given-names></name><name><surname>Khalikov</surname><given-names>SS</given-names></name><etal/></person-group>
<article-title>Innovative technology for preparing of anthelmintic drugs</article-title>. <source>Veterinary</source>. <year>2016</year>; <volume>12</volume>:<fpage>3</fpage>&#x02013;<lpage>10</lpage>.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="other"><article-title>The order of the Ministry of Health of the USSR, October 10th, 1983, No. 1179</article-title> &#x0201c;On approval of feed standards for laboratory animals in health facilities&#x0201d;.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Astafyev</surname><given-names>BA</given-names></name><name><surname>Yarotsky</surname><given-names>LS</given-names></name><name><surname>Lebedeva</surname><given-names>MN.</given-names></name></person-group>
<source>Experimental models of parasites in biology and medicine</source>. <publisher-loc>Moscow</publisher-loc>: <publisher-name>Nauka</publisher-name>; <year>1989</year>.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kalashnikov</surname><given-names>AP</given-names></name><name><surname>Fisin</surname><given-names>VF</given-names></name><name><surname>Shcheglova</surname><given-names>VV</given-names></name><etal/></person-group>
<source>Norms and rations of feeding livestock</source>. <publisher-loc>Moscow</publisher-loc>: <publisher-name>Rosselkhozakademiya</publisher-name>; <year>2003</year>.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>Ministry of Agriculture, Fisheries and Food.</collab></person-group>
<source>Manual of veterinary parasitological laboratory techniques</source>. Reference Book 418. <publisher-loc>London</publisher-loc>: <publisher-name>Her Majesty&#x02019;s Stationery Office</publisher-name>; <year>1986</year>.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wood</surname><given-names>IB</given-names></name><name><surname>Amaral</surname><given-names>NK</given-names></name><name><surname>Bairden</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>World Association for the Advancement of Veterinary Parasitology (WAAVP) second edition of guidelines for evaluating the efficacy of anthelmintics in ruminants (bovine, ovine, caprine)</article-title>. <source>Vet Parasitol</source>. <year>1995</year>; <volume>58</volume>(<issue>3</issue>):<fpage>181</fpage>&#x02013;<lpage>213</lpage>.<pub-id pub-id-type="pmid">7571325</pub-id></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ivashkin</surname><given-names>VM</given-names></name><name><surname>Oripov</surname><given-names>AO</given-names></name><name><surname>Sonin</surname><given-names>MD.</given-names></name></person-group>
<source>The determinant of helminthes of small cattle</source>. <publisher-loc>Moscow</publisher-loc>: <publisher-name>Nauka</publisher-name>; <year>1989</year>.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Arkhipov</surname><given-names>IA.</given-names></name></person-group>
<source>Anthelmintics: pharmacology and application</source>. <publisher-loc>Moscow</publisher-loc>: <publisher-name>Rosselkhozakademiya</publisher-name>; <year>2009</year>.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linderberg</surname><given-names>M</given-names></name><name><surname>Kopp</surname><given-names>S</given-names></name><name><surname>Dressman</surname><given-names>JB.</given-names></name></person-group>
<article-title>Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system</article-title>. <source>Eur J Pharm Biopharm</source>. <year>2004</year>; <volume>58</volume>(<issue>2</issue>):<fpage>265</fpage>&#x02013;<lpage>78</lpage>.<pub-id pub-id-type="pmid">15296954</pub-id></mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dayan</surname><given-names>AD.</given-names></name></person-group>
<article-title>Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics</article-title>. <source>Acta Trop</source>. <year>2003</year>; <volume>86</volume>(<issue>2&#x02013;3</issue>):<fpage>141</fpage>&#x02013;<lpage>59</lpage>.<pub-id pub-id-type="pmid">12745134</pub-id></mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skira</surname><given-names>VN</given-names></name><name><surname>Dushkin</surname><given-names>AV</given-names></name><name><surname>Chistyachenko</surname><given-names>YS</given-names></name><etal/></person-group>
<article-title>Efficacy of the supramolecular complex of fenbendazole in nematodiasis of sheep</article-title>. <source>Rus Parasitol J</source>. <year>2016</year>; <fpage>76</fpage>&#x02013;<lpage>81</lpage>.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>R</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Meteleva</surname><given-names>ES</given-names></name><etal/></person-group>
<article-title>Enhanced solubility and bioavailability of simvastatin mechanochemically obtained complexes</article-title>. <source>Int J Pharm</source>. <year>2017</year>; <volume>534</volume>(<issue>1&#x02013;2</issue>):<fpage>108</fpage>&#x02013;<lpage>118</lpage>.<pub-id pub-id-type="pmid">28993167</pub-id></mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selyutina</surname><given-names>OY</given-names></name><name><surname>Apanasenko</surname><given-names>IE</given-names></name><name><surname>Polyakov</surname><given-names>NE.</given-names></name></person-group>
<article-title>Membrane-modifying activity of glycyrrhizic acid</article-title>. <source>Russ Chem Bull</source>. <year>2015</year>; <volume>64</volume>:<fpage>1555</fpage>&#x02013;<lpage>1559</lpage>.</mixed-citation></ref></ref-list></back></article>